Real-world results of first-line ABVD in patients with classic Hodgkin's lymphoma at a neoplastic disease institute in Lima, Peru.

Objective: To evaluate the clinical characteristics and outcomes of first-line ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) in patients with classical Hodgkin lymphoma treated at a neoplastic disease institute in Lima, Peru. Methods: Retrospective study of previously untreated classical H...

Descripción completa

Detalles Bibliográficos
Publicado en:Revista Medica Herediana Vol. 36; no. 4; pp. 332 - 345
Autores principales: Salinas Agramonte, Luis, Valencia Laurel, Grethel, Alcarraz, Cindy, Mantilla, Raúl, Quintana, Shirley, Vásquez, Jule, Rioja, Patricia, Bendezú, Elmer, Motta Guerrero, Rodrigo, Vidaurre, Tatiana
Formato: research tables/charts Journal Article
Publicado: Universidad Peruana Cayetano Heredia Oct-Dec2025
Acceso en línea:Ver este registro en EBSCOhost